KIMS — Krishna Institute of Medical Sciences Share Price
Last trade - 00:00- IN₹158.29bn
- IN₹168.83bn
- IN₹21.98bn
- 73
- 11
- 74
- 53
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 41.06 | ||
| PEG Ratio (f) | 2.98 | ||
| EPS Growth (f) | 15.97% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.73 | ||
| Price to Tang. Book | 11.05 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.49 | ||
| EV to EBITDA | 26.19 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.64% | ||
| Return on Equity | 20% | ||
| Operating Margin | 20.86% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 9,180.05 | 11,226.45 | 13,299.37 | 16,508.25 | 21,976.78 | 25,299.29 | 29,525.86 | 27.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +68.05 | +66.93 | -3.72 | +2.37 | +15.97 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Krishna Institute of Medical Sciences Ltd is an India-based company that is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center and hepatobiliary surgery center. Its technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, and Impella. The Company’s institutes include the institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, and Institute of Neuro Sciences.
Directors
- B. Krishnaiah CHM
- B.Bhaskar Rao CEO
- K.V. Krishna Kumar DRC
- P.Rajendra Kumar Jain DRC
- M.Sambasiva Rao DRC
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 26th, 1973
- Public Since
- June 28th, 2021
- No. of Shareholders
- 61,528
- No. of Employees
- 10,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 80,027,787
- Address
- 1-8-31/1, Minister Road, SECUNDERABAD, 500003
- Web
- https://www.kimshospitals.com/
- Phone
- +91 4044885000
- Contact
- Uma Shankar Mantha
- Auditors
- S.R. BATLIBOI & ASSOCIATES LLP
Upcoming Events for KIMS
Similar to KIMS
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Dr. Lal PathLabs
National Stock Exchange of India
FAQ
As of Today at 19:12 UTC, shares in Krishna Institute of Medical Sciences are trading at IN₹1,977.95. This share price information is delayed by 15 minutes.
Shares in Krishna Institute of Medical Sciences last closed at IN₹1,977.95 and the price had moved by +33.29% over the past 365 days. In terms of relative price strength the Krishna Institute of Medical Sciences share price has outperformed the S&P BSE 100 Index by +1.02% over the past year.
The overall consensus recommendation for Krishna Institute of Medical Sciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Krishna Institute of Medical Sciences does not currently pay a dividend.
Krishna Institute of Medical Sciences does not currently pay a dividend.
Krishna Institute of Medical Sciences does not currently pay a dividend.
To buy shares in Krishna Institute of Medical Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1,977.95, shares in Krishna Institute of Medical Sciences had a market capitalisation of IN₹158.29bn.
Here are the trading details for Krishna Institute of Medical Sciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: KIMS
Based on an overall assessment of its quality, value and momentum Krishna Institute of Medical Sciences is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Krishna Institute of Medical Sciences is IN₹2,350.14. That is 18.82% above the last closing price of IN₹1,977.95.
Analysts covering Krishna Institute of Medical Sciences currently have a consensus Earnings Per Share (EPS) forecast of IN₹41.53 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Krishna Institute of Medical Sciences. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -12.86%.
As of the last closing price of IN₹1,977.95, shares in Krishna Institute of Medical Sciences were trading -0.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Krishna Institute of Medical Sciences PE ratio based on its reported earnings over the past 12 months is 41.06. The shares last closed at IN₹1,977.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Krishna Institute of Medical Sciences' management team is headed by:
- B. Krishnaiah - CHM
- B.Bhaskar Rao - CEO
- K.V. Krishna Kumar - DRC
- P.Rajendra Kumar Jain - DRC
- M.Sambasiva Rao - DRC